ABVC BIOPHARMA, INC. (ABVC) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.39 | +7.1% |
| 2024 | $-0.42 | +76.7% |
| 2023 | $-1.80 | +65.3% |
| 2022 | $-5.19 | -917.6% |
| 2021 | $-0.51 | -2.0% |
| 2020 | $-0.50 | — |
| 2018 | $-0.02 | +0.0% |
| 2017 | $-0.02 | +66.7% |
| 2016 | $-0.06 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.39 | +7.1% |
| 2024 | $-0.42 | +76.7% |
| 2023 | $-1.80 | +65.3% |
| 2022 | $-5.19 | -917.6% |
| 2021 | $-0.51 | -2.0% |
| 2020 | $-0.50 | — |
| 2018 | $-0.02 | +0.0% |
| 2017 | $-0.02 | +66.7% |
| 2016 | $-0.06 | — |